Pharmacoepidemiological studies using large healthcare databases have found associations between GLP-1 agonist use and reduced rates of alcohol-related hospitalizations, emergency department visits, and new diagnoses of alcohol use disorder
The key findings were as follows: Patients who underwent cryoanalgesia showed a significant reduction in opioid consumption on both day 7 and day 14 after surgery, as well as throughout the entire hospital stay
DEHP and its hydrolyzed product mono(2-ethylhexyl) phthalate (MEHP) were found in critically ill neonates and also in adults, causing various anti-androgenic effects leading to reproductive and developmental disorders [14]
In vivo studies with a commonly used animal model of obesity-diabetes and enteroendocrine hyperactivity show that both GIP and GLP-1 play an important role in mediating postprandial insulin release
What Research Shows About Weight After Stopping GLP-1 Data reveal a common pattern of weight regain following discontinuation
High iron and low ascorbic acid concentrations in the dermis of atopic dermatitis patients